INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo KOGENATE FS

For full prescribing information refer to the package insert approved by the medicines regulatory authority.

SCHEDULING STATUS:
No data

PROPRIETARY NAME
(and dosage form):

KOGENATE FS

COMPOSITION:
Each vial of KOGENATE FS 250 contains
Octocog alfa 250,0 I.U
Each vial of KOGENATE FS 500 contains Octocog alfa 500,0 I.U
Each vial of KOGENATE FS 1 000 contains Octocog alfa 1 000,0 I.U

ATC CLASSIFICATION:
B02BD

PRESENTATION/PACK SIZE:
no data

REGISTRATION NUMBER:
KOGENATE FS 250                41/8.1/1086
KOGENATE FS 500                41/8.1/1087
KOGENATE FS 1 000         41/8.1/1088

APPLICANT:
BAYER (PTY) LTD

AVAILABILITY:
no data - please check with company.

DATE OF REGISTRATION:
05 December 2013

SOURCE:
MEDICINES CONTROL COUNCIL- REGISTRAR OF MEDICINES
12.43 Notification of Registration Oct08 v1.doc        Nov 2008

Date posted: August 2014

LINKS:
kogenatefs.com
Full Prescribing Information for Kogenate FS with BIO-SET®, antihemophilic factor (recombinant), Kogenate FS with Vial Adapterand Kogenate FS is available in a downloadable PDF file
http://www.kogenatefs.com/index.php/home/prescribing-information

NHSchoices
http://www.nhs.uk/medicine-guides/pages/MedicineOverview.aspx?condition=Blood%20clotting&medicine=octocog%20alfa

eMC Medicine Guides
http://www.medicines.org.uk/guides/octocog%20alfa/blood%20clotting

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2014